{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:35:43Z","timestamp":1791005743483,"version":"4.1.0"},"reference-count":61,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s321789","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:44:05Z","timestamp":1629467045000},"page":"877-887","source":"Crossref","is-referenced-by-count":5,"title":["Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Nayoung","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1836-1707","authenticated-orcid":true,"given":"Jung Mi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-3343","authenticated-orcid":true,"given":"In-Wha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1111\/bcp.13394","volume":"83","author":"Aronson","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-018-0186-y","volume":"14","author":"Balan","year":"2018","journal-title":"World J Pediatr"},{"key":"ref3","first-page":"316","volume":"20","author":"Corny","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e20190896","DOI":"10.1542\/peds.2019-0896","volume":"144","author":"Hoon","year":"2019","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.2082","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinternmed.2012.340","volume":"172","author":"Eguale","year":"2012","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","volume":"166","author":"Radley","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/2279-042X.155755","volume":"4","author":"Golchin","year":"2015","journal-title":"J Res Pharm Pract"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2165\/11633520-000000000-00000","volume":"29","author":"Jackson","year":"2012","journal-title":"Drugs Aging"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ddr.21176","volume":"75","author":"Kumar Kakkar","year":"2014","journal-title":"Drug Dev Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/wmh3.131","volume":"7","author":"Gibson","year":"2015","journal-title":"World Med Health Policy"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1021\/acsmedchemlett.8b00438","volume":"9","author":"Mingorance","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.2174\/1381612824666171129193258","volume":"23","author":"Zhao","year":"2017","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/21678707.2016.1120664","volume":"4","author":"Bloom","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/21678707.2017.1402676","volume":"5","author":"Cohen","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/jamainternmed.2015.6058","volume":"176","author":"Eguale","year":"2016","journal-title":"JAMA Intern Med"},{"key":"ref18","first-page":"477","volume":"340","author":"Shapiro","year":"1999","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/pds.3213","volume":"21","author":"Fournier","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/bmj.329.7456.44","volume":"329","author":"Stricker","year":"2004","journal-title":"BMJ"},{"key":"ref22","unstructured":"U.S.Food & Drug Administration. FDA adverse event reporting system (FAERS): latest quarterly data files. Available from: https:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm082193.htm. Accessed August 12, 2021."},{"key":"ref23","unstructured":"Korea Institute of Drug Safety and Risk Management. User guide: Korea institute of drug safety and risk management-Korea adverse event reporting system database (KIDS-KD). Available from: https:\/\/www.drugsafe.or.kr\/iwt\/ds\/ko\/openinfo\/DrugAdrDataProc.do. Accessed August 12, 2021."},{"key":"ref24","unstructured":"ICH Legal Mention. MedDRA. Medical dictionary for regulatory activities. Available from: https:\/\/www.meddra.org\/. Accessed August 12, 2021."},{"key":"ref25","unstructured":"Uppsala Monitoring Center. The WHO-ART adverse reaction terminology. Available from: http:\/\/www.umc-products.com\/graphics\/3149.pdf. Accessed August 12, 2021."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40264-020-01035-x","volume":"44","author":"Beyzarov","year":"2021","journal-title":"Drug Saf"},{"key":"ref27","unstructured":"U. S. Food & Drug Administration. CFR-code of federal regulations title 21. sec 201.57 (c) (9) (iv) (4). Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=201.57. Accessed August 12, 2021."},{"key":"ref28","unstructured":"ICH Harmonised Guideline. Addendum To ICH E11: clinical investigation of medicinal products in the pediatric population E11 (R1). Available from: https:\/\/www.meddra.org\/. Accessed August 12, 2021."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2165\/00002018-200730070-00009","volume":"30","author":"Mozzicato","year":"2007","journal-title":"Drug Saf"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"105866","DOI":"10.1016\/j.intimp.2019.105866","volume":"76","author":"Fan","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jamia\/ocv063","volume":"23","author":"Duggirala","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"113168","DOI":"10.1016\/j.bbr.2021.113168","volume":"404","author":"Cepaityte","year":"2021","journal-title":"Behav Brain Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11523-020-00738-6","volume":"15","author":"Raschi","year":"2020","journal-title":"Target Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/ph14050425","volume":"14","author":"Choi","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e0212336","DOI":"10.1371\/journal.pone.0212336","volume":"14","author":"Oh","year":"2019","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2125.1998.00817.x","volume":"46","author":"Martin","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","volume":"320","author":"Pouyanne","year":"2000","journal-title":"BMJ"},{"key":"ref42","first-page":"776","volume":"111","author":"Allen","year":"2018","journal-title":"J Okla State Med Assoc"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/pds.4289","volume":"26","author":"Schroder","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1741-7015-11-238","volume":"11","author":"Bellis","year":"2013","journal-title":"BMC Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.compbiolchem.2014.01.006","volume":"50","author":"Mizutani","year":"2014","journal-title":"Comput Biol Chem"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/bcp.13067","volume":"82","author":"Hawcutt","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"Lopez-Gonzalez","year":"2009","journal-title":"Drug Saf"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF03319101","volume":"35","author":"Salvi","year":"2012","journal-title":"Drug Saf"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/flgastro-2013-100316","volume":"5","author":"Philpott","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ibd.22990","volume":"19","author":"Dubeau","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6904-11-2","volume":"11","author":"Fosnes","year":"2011","journal-title":"BMC Clin Pharmacol"},{"key":"ref53","unstructured":"U.S. Department of Health and Human Services. National action plan for adverse drug event prevention. Available from: https:\/\/health.gov\/hcq\/pdfs\/ade-action-plan-508c.pdf. Accessed August 12, 2021."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1038\/s41598-021-83099-y","volume":"11","author":"Wu","year":"2021","journal-title":"Sci Rep"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00228-019-02810-1","volume":"76","author":"Lassalle","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/19420862.2018.1556465","volume":"11","author":"Kaplon","year":"2019","journal-title":"MAbs"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/pds.4970","volume":"29","author":"Dijkstra","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1517\/14740338.2014.915938","volume":"13","author":"Hou","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/clpt.2012.24","volume":"91","author":"Dal Pan","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fphar.2020.00621","volume":"11","author":"Mascolo","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/jcpt.13209","volume":"45","author":"Li","year":"2020","journal-title":"J Clin Pharm Ther"}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72843","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72843","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:44:17Z","timestamp":1629467057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/adverse-events-related-to-off-label-drugs-using-spontaneous-adverse-ev-peer-reviewed-fulltext-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":61,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s321789","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}